|
|
 | | | |
- close
- close
- close
- close
Austral Pacific Energy (AEN) |
OilVoice
Apr 11
Comment
The Board of Andes AIM AEN BCBA AEN is pleased to announce the successful completion of the acquisition from local South American investors of 100 of the issued share capital of Ketsal S.A. qu
OilVoice
Mar 11
Comment
The Board of Andes AIM AEN BCBA AEN is pleased to announce the successful completion of the acquisition of 100 of the issued share capital of Kilwer S.A. 39Kilwer39 a private oil and ga
OilVoice
Jan 14
Comment
The Board of Andes AIM AEN BCBA AEN the Latin American EP company is pleased to give an operational update after the first production optimisation campaign undertaken by the company as operato
Benzinga
Feb 16
Comment
Adeona Pharmaceuticals, Inc. (NYSE: AEN] announced today that it received approval at yesterday's special meeting of stockholders to change its corporate name to Synthetic Biologics, Inc. It is expected that the Company's shares will start trading...
StreetInsider.com
Feb 7
Comment
Visit StreetInsider.com at http://www.streetinsider.com/Management+Changes/Adeona+%28AEN%29+Names+C.+Evan+Ballantyne+as+CFO/7142083.html for the full story.
StreetInsider.com
Feb 6
Comment
Visit StreetInsider.com at http://www.streetinsider.com/Management+Changes/Adeona+%28AEN%29+Appoints+Chairman+Jeff+Riley+as+CEO%3B+Names+Two+Board+Members/7137894.html for the full story.
StreetInsider.com
Dec 21
Comment
Visit StreetInsider.com at http://www.streetinsider.com/Corporate+News/Adeona+Pharmaceuticals+%28AEN%29+Announces+Possible+Name+Change%2C+Appoints+John+Monahan+Senior+VP+of+R%26D/7035358.html for the full story.
StreetInsider.com
Nov 30
Comment
Visit StreetInsider.com at http://www.streetinsider.com/Corporate+News/Adeona+%28AEN%29+Reports+Encouraging+Data+from+Zinc+Therapy+Phase+III+in+ALS/6983049.html for the full story.
StreetInsider.com
Nov 21
Comment
Visit StreetInsider.com at http://www.streetinsider.com/Corporate+News/Adeona+%28AEN%29%2C+Intrexon+Unit+Enter+PAH+Treatment+Collaboration/6965262.html for the full story.
StreetInsider.com
Sep 19
Comment
Visit StreetInsider.com at http://www.streetinsider.com/Corporate+News/Adeona+%28AEN%29+Completes+Enrollment+in+Trimesta+Trial%3B+Receives+Additional+Funding/6794621.html for the full story.
Suggest other news sources for this topic
more ▼WIKI ANALYSIS
WIKI ANALYSIS|
Error creating thumbnail: convert: unable to open image `/home/wikinvest/src_live_1/mediawiki/images/9/98/New_stock.png': No such file or directory @ blob.c/OpenBlob/2480. convert: unable to open file `/home/wikinvest/src_live_1/mediawiki/images/9/98/New_stock.png' @ png.c/ReadPNGImage/2889. convert: missing an image filename `/home/wikinvest/src_live_1/mediawiki/images/thumb/9/98/New_stock.png/35px-New_stock.png' @ convert.c/ConvertImageCommand/2800. |
The article on this company has not been written yet. If you're the first person to write this article, it's a sure thing that you'll be credited as a Top Contributor. For tips on getting started, check out the sample article. |
Adeona Pharmaceuticals, Inc. (Adeona) is a development-stage pharmaceutical company developing medicines for central nervous systems diseases. Trimesta (estriol) is an investigational oral drug for the treatment of relapsingremitting multiple sclerosis. ZinthioneinTM ZC (zinc cysteine) is an oral, gastro-retentive, sustained-release medical food candidate being developed for the dietary management of Alzheimer’s disease and mild cognitive impairment. In December of 2009, Adeona initiated a 60-patient clinical study. Effirma (flupirtine) is an investigational oral drug for the treatment of fibromyalgia syndrome. dnaJP1 (hsp peptide) is an investigational oral drug for the treatment of rheumatoid arthritis. CD4 Inhibitor 802-2 (cyclic heptapeptide) is an investigational drug for the prevention of severe graft-versus-host disease. On July 10, 2009 the Company acquired Hart Lab, LLC.
References
| |||||||
